ACTIVE SUBSTANCE / INN

LAQUINIMOD

Brand name(s): Nerventra
EMA LISTED
REFUSED
Multiple Sclerosis
ACTIVE SUBSTANCE
Laquinimod
REGULATORS
EMA
SPONSORS / MAH
Teva Pharma GmbH
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
NerventraTeva Pharma GmbHRefusedMultiple Sclerosis

FULL INTELLIGENCE ON LAQUINIMOD

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →